Patients with a body mass index BMI of 30 or more, or a BMI of 27 with related conditions, will receive 2.4 mg injections once per week
The platform is designed to provide continuity of care through regular check-ins, refill scheduling, and clinician oversight without requiring in-person visits
Vomiting and stomach pain happen more often with Mounjaro, likely due to its stronger overall effect
Im not in the place yet
Improved overall health: Achieving optimal nutrition and maintaining a healthy weight can positively impact your overall health, from reducing inflammation to improving immune function
In a single piece, he concisely captures: the state of the field the most important clinical trials where the pipeline is headed These Clinical trials are raising the bar and expanding future treatment options: Retatrutide ~24% weight loss (triple agonist) MariTide 1216% weight loss (GLP-1 + GIP antagonist) CagriSema up to 20% weight loss + ~2% HbA1c drop Orforglipron oral GLP-1, HbA1c 1.5%, weight 7.6% IcoSema weekly semaglutide + once-weekly insulin Even more exciting